Notice: This company has been marked as potentially delisted and may not be actively trading. Imunon (CLSN) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Imunon Inc IMNNMarch 10, 2024 | morningstar.comCLSN.L Regulatory NewsMay 22, 2023 | lse.co.ukCelsion Corporation Advances Proof of Concept to Non-human Primate Challenge Study Against SARS-CoV-2 with In-Process Vaccine Candidate - Marketscreener.comOctober 9, 2022 | marketscreener.comImunon Reports Partial Results from Ongoing Non-human Primate Study - GlobeNewswireOctober 3, 2022 | globenewswire.comImunon Appoints James E. Dentzer to its Board of Directors - GlobeNewswireOctober 3, 2022 | globenewswire.comImunon Reports Inducement Grants under NASDQ Listing Rule 5646(c)(4) - GlobeNewswireSeptember 29, 2022 | globenewswire.comIMUNON to Present at Chardan's 6th Annual Genetic Medicines - GlobeNewswireSeptember 28, 2022 | globenewswire.comCelsion Corporation Announces Company Name Change to Imunon, Inc. - GlobeNewswireSeptember 19, 2022 | globenewswire.comCelsion Corporation Announces Company Name Change to Imunon, Inc.September 19, 2022 | finance.yahoo.comCelsion Completes Enrollment of the Phase I/II OVATION 2 Study with GEN-1 in Advanced Ovarian Cancer - GlobeNewswireSeptember 15, 2022 | globenewswire.comCelsion Completes Enrollment of the Phase I/II OVATION 2 Study with GEN-1 in Advanced Ovarian CancerSeptember 15, 2022 | finance.yahoo.comCelsion (NASDAQ:CLSN) – Celsion Corporation Presentation Time at the H.C. Wainwright 24th Annual Global I - BenzingaSeptember 12, 2022 | benzinga.comCelsion Corporation Presentation Time at the H.C. Wainwright 24th Annual Global Investment Conference Changed to 4:30 p.m. ET on September 13September 12, 2022 | finance.yahoo.comCelsion (NASDAQ:CLSN) – Celsion Earnings Perspective: Return On Capital Employed - BenzingaSeptember 9, 2022 | benzinga.comCelsion Earnings Perspective: Return On Capital EmployedSeptember 9, 2022 | msn.comCelsionoration (CLSN) – Celsion Corporation to Present at the H.C. Wainwright 24th Annual Global Investme - BenzingaSeptember 7, 2022 | benzinga.comCelsion Corporation to Present at the H.C. Wainwright 24th - GlobeNewswireSeptember 7, 2022 | globenewswire.comCelsion Corporation to Present at the H.C. Wainwright 24th Annual Global Investment ConferenceSeptember 7, 2022 | finance.yahoo.comCLSN.OQ - Celsion Corporation | Stock Price & Latest News | ReutersSeptember 5, 2022 | reuters.comCelsion Corporation Highlights Progress in its DNA-based Vaccine Program - GlobeNewswireSeptember 1, 2022 | globenewswire.comCelsion Corporation Highlights Progress in its DNA-based Vaccine ProgramSeptember 1, 2022 | finance.yahoo.comCLSN: Complete Enrollment of OVATION 2 Study Expected in 3Q22…August 30, 2022 | finance.yahoo.comCelsion GAAP EPS of -$0.87, revenue of $0.13M - Seeking AlphaAugust 15, 2022 | seekingalpha.comCELSION CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q) - Marketscreener.comAugust 15, 2022 | marketscreener.comRecap: Celsion Q2 Earnings - BenzingaAugust 15, 2022 | benzinga.comCelsion Corporation Reports Second Quarter 2022 Financial Results and Provides Business Update - GlobeNewswireAugust 15, 2022 | globenewswire.comCelsion Corporation Reports Second Quarter 2022 Financial Results and Provides Business UpdateAugust 15, 2022 | finance.yahoo.comCelsion Q2 2022 Earnings PreviewAugust 14, 2022 | seekingalpha.comCelsion Corporation to Hold Second Quarter 2022 Financial Results and Business Update Conference Call on Monday, August 15, 2022 - GlobeNewswireAugust 9, 2022 | globenewswire.comCelsion Corporation to Hold Second Quarter 2022 Financial Results and Business Update Conference Call on Monday, August 15, 2022August 8, 2022 | finance.yahoo.comCelsion Appoints Corinne Le Goff To Succeed Michael Tardugno As President And CEOJuly 21, 2022 | nasdaq.comU.S. Stocks May Move Back To The Upside After Yesterday's Downturn - NasdaqJuly 19, 2022 | nasdaq.comNasdaq Bear Market: 1 Growth Stock Down More Than 90% to Buy Now - NasdaqJuly 19, 2022 | nasdaq.comCelsion Appoints Dr. Corinne Le Goff as President and Chief Executive Officer - GlobeNewswireJuly 19, 2022 | globenewswire.comCelsion Appoints Dr. Corinne Le Goff as President and Chief Executive OfficerJuly 19, 2022 | finance.yahoo.comCelsion Corporation Reports Inducement Grants under NASDQ Listing Rule 5646(c)(4)July 19, 2022 | finance.yahoo.comCelsion Reports Data Safety Monitoring Board Unanimous Recommendation to Continue Dosing Patients in the Phase II Portion of the OVATION 2 Study with GEN-1 in Advanced Ovarian Cancer - GlobeNewswireJune 21, 2022 | globenewswire.comCelsion Corporation Highlights Pipeline Progress in Its Lead Development Candidates - GuruFocus.comJune 20, 2022 | gurufocus.comCLSN: OVATION 2 Study 85% Enrolled… - Benzinga - BenzingaJune 18, 2022 | benzinga.comCELSION CORP : Submission of Matters to a Vote of Security Holders (form 8-K) - Marketscreener.comJune 14, 2022 | marketscreener.comCLSN: OVATION 2 Study 85% Enrolled…June 13, 2022 | finance.yahoo.comGlobal Nucleic Acid Based Gene Therapy Market to 2031 - Featuring BioMedica, Transgene and Copernicus Therapeutics Among Others - ResearchAndMarkets.com - Business WireJune 9, 2022 | businesswire.comNucleic Acid Based Gene Therapy Global Market Report 2022 - Yahoo FinanceMay 30, 2022 | finance.yahoo.comAdvanced Clinical Trials Focus on Development of Vaccines to Prevent Ovarian Cancer Progression - StreetInsider.comMay 20, 2022 | streetinsider.comCelsion Corporation Reports First Quarter 2022 Financial Results and Provides Business Update - GlobeNewswireMay 17, 2022 | globenewswire.comCelsion: Q1 Earnings Insights - Benzinga - BenzingaMay 16, 2022 | benzinga.comEarnings Outlook For CelsionMay 14, 2022 | benzinga.comCelsion Q4 2022 Earnings PreviewMay 14, 2022 | seekingalpha.comCelsion Corporation to Hold First Quarter 2022 Financial Results and Business Update Conference Call on Monday, May 16, 2022 - StreetInsider.comMay 11, 2022 | streetinsider.comCelsion Corporation Highlights Pipeline Progress in Its Lead Development Candidates - GlobeNewswireMay 10, 2022 | globenewswire.com Get Imunon News Delivered to You Automatically Sign up to receive the latest news and ratings for CLSN and its competitors with MarketBeat's FREE daily newsletter. Email Address Do this Before Elon’s Reveal on January 22nd (Ad)Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen. I urge you to watch this video now. CLSN Media Mentions By Week CLSN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CLSN News Sentiment▼0.000.45▲Average Medical News Sentiment CLSN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CLSN Articles This Week▼00▲CLSN Articles Average Week Get Imunon News Delivered to You Automatically Sign up to receive the latest news and ratings for CLSN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies IMRX News Today STTK News Today FBIO News Today ITRM News Today IOBT News Today CELU News Today CASI News Today KZR News Today VTVT News Today XCUR News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CLSN) was last updated on 12/19/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Imunon, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Imunon With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CLSN Stock Alerts